Houston-based accelerator to provide platform for growth to early stage life sciences and biotech companies HOUSTON, Sept. 24, 2019 /PRNewswire/ — Houston Healthspan Innovation Group is a new accelerator for early stage life sciences and biotech companies focused on the research, development and commercialization of new therapies and technologies in the expanding field of regenerative […]
Author Archive for: wpadmin5689
This author has yet to write their bio.Meanwhile lets just say that we are proud Webmaster contributed a whooping 5 entries.
Entries by Webmaster
New leading-edge technology produces higher yields of stem cells to enhance patient treatments HOUSTON, Aug. 21, 2019 /PRNewswire/ — Tissue Genesis, a leading developer of cell therapy processing systems, announced today that an initial group of patients was successfully treated in the first clinical application of its Icellator® X technology at the Okyanos Center for […]
Promising anti-aging stem cell therapy AR-100 shows potential in the treatment of age-related diseases HOUSTON, May 29, 2019 — Rejenevie™ Therapeutics announced the commencement of the company’s Phase II clinical trial to study the safety and effectiveness of its proprietary AR-100 immune restoration therapy to boost the function of the aging immune system. The clinical-stage […]
ATLANTA (April 1, 2019) – W.E. “Ed” Bosarge Jr., PhD gave remarks Monday, April 1st, at the American Association of Cancer Research’s annual meeting in Atlanta. He introduced this year’s recipient of the AACR-Waun Ki Hong Award for Outstanding Achievement in Cancer Research, Dr. Andrew T. Chan. Bosarge endows this $10,000 award given annually to an outstanding cancer researcher […]
HOUSTON (Nov. 1, 2017) – Human Life CORD Japan, Inc., (HLC) a group company of Nihon Trim (Cord No. 6788, Tokyo Stock Exchange 1st Section) is pleased to announce a strategic agreement with Tissue Genesis, LLC (TG) to distribute its proprietary stem cell processing products in commercial clinics, research institutions, and hospitals in Japan and China. […]